[Agents to improve cerebrovascular circulation and cerebral metabolism--cellryl].
D000818:Animals; D000897:Anti-Ulcer Agents; D001921:Brain / Q000378:metabolism*; D002543:Cerebral Hemorrhage / Q000188:drug therapy; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004285:Dogs; D004311:Double-Blind Method; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D007928:Lethal Dose 50; D008297:Male; D010101:Oxygen Consumption / Q000187:drug effects*; D051381:Rats; D014020:Tissue Extracts / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity
D000897:Anti-Ulcer Agents; D014020:Tissue Extracts; C045563:cellryl